Injectable nanogel can monitor blood-sugar levels and secrete insulin when needed.
Dr. William Spencer, chairman of the board and former CEO of Sematech, will share his views on the semiconductor industry on Tuesday, April 28 at 4pm in the Wong Auditorium (Building E51).
The 90-minute presentation and discussion, entitled "R&D Cooperation in the Semiconductor Industry: What It Is, What It Isn't, What are the Lessons," is part of the Industry Leaders in Technology and Management lecture series, co-sponsored by the School of Engineering and the Sloan School and hosted by the Center for Technology, Policy and Industrial Development.
Dr. Spencer has worked in research and management at Bell Labs (1959-73), Sandia National Labs (1973-81) and Xerox (1981-90). He joined Sema-tech in 1990 as president and CEO. He holds the AB from William Jewell College in Missouri and the MS and PhD from Kansas State University.
Sematech is a research and development consortium of 16 international corporations involved in semiconductor manufacturing. The consortium has worked to develop equipment and materials needed to advance existing technologies and to increase efficiency and cost effectiveness, as well as focusing on revolutionary changes needed by the industry.
Sematech and/or its member companies participate in a number of initiatives at MIT. Examples include collaboration on the modeling of advance copper-interconnect technology and industrial participation in the SRC/NSF Engineering Research Center for Environmentally Benign Semiconductor Manufacturing and the Microsystems Technology Laboratory.
Dr. Spencer's lecture is open to the MIT community. Seating is limited to a first-come, first-served basis. For more information, call x3-0404 or refer to the CTPID homepage at http://web.mit.edu/ctpid/www.
A version of this article appeared in MIT Tech Talk on April 15, 1998.